HCPCS Level II
J9024
Injection, atezolizumab, 5 mg and hyaluronidase-tqjs
Codes near J9024
These sit next to J9024 in the CMS Level II file. All J codes
- J9019Injection, asparaginase (erwinaze), 1, 000 iu
- J9020Injection, asparaginase, not otherwise specified, 10, 000 units
- J9021Injection, asparaginase, recombinant, (rylaze), 0.1 mg
- J9022Injection, atezolizumab, 10 mg
- J9023Injection, avelumab, 10 mg
- J9025Injection, azacitidine, 1 mg
- J9026Injection, tarlatamab-dlle, 1 mg
- J9027Injection, clofarabine, 1 mg
- J9028Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram
- J9029Intravesical instillation, nadofaragene firadenovec-vncg, per therapeutic dose
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 50242-0933-01 | Tecentriq Hybreza | Genentech, Inc. | 375 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.